Cancer-associated fibroblasts downregulate type I interferon receptor to stimulate intratumoral stromagenesis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer-associated fibroblasts downregulate type I interferon receptor to stimulate intratumoral stromagenesis
Authors
Keywords
-
Journal
ONCOGENE
Volume 39, Issue 38, Pages 6129-6137
Publisher
Springer Science and Business Media LLC
Online
2020-08-18
DOI
10.1038/s41388-020-01424-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An Interferon-Driven Oxysterol-Based Defense against Tumor-Derived Extracellular Vesicles
- (2019) Angelica Ortiz et al. CANCER CELL
- Cancer-associated fibroblasts enhance tumor-associated macrophages enrichment and suppress NK cells function in colorectal cancer
- (2019) Rongsheng Zhang et al. Cell Death & Disease
- Deletion of Calcineurin Promotes a Protumorigenic Fibroblast Phenotype
- (2019) Allyson Lieberman et al. CANCER RESEARCH
- Cancer-Associated Fibroblasts Affect Intratumoral CD8+and FoxP3+T Cells via Interleukin 6 in the Tumor Microenvironment
- (2018) Takuya Kato et al. CLINICAL CANCER RESEARCH
- Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy
- (2018) Jinyang Li et al. IMMUNITY
- Targeting the tumour stroma to improve cancer therapy
- (2018) Kenneth C. Valkenburg et al. Nature Reviews Clinical Oncology
- IL-1-induced JAK/STAT signaling is antagonized by TGF-beta to shape CAF heterogeneity in pancreatic ductal adenocarcinoma
- (2018) Giulia Biffi et al. Cancer Discovery
- Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
- (2017) Daniel Öhlund et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Smad7 enables STAT3 activation and promotes pluripotency independent of TGF-β signaling
- (2017) Yi Yu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Stromal dynamic reciprocity in cancer: intricacies of fibroblastic-ECM interactions
- (2016) Jennifer Alexander et al. CURRENT OPINION IN CELL BIOLOGY
- Carcinoma-associated fibroblasts: orchestrating the composition of malignancy
- (2016) Philippe Gascard et al. GENES & DEVELOPMENT
- Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms
- (2016) Amy R Peck et al. MODERN PATHOLOGY
- Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression
- (2016) Yuliya V. Katlinskaya et al. Cell Reports
- Can Targeting Stroma Pave the Way to Enhanced Antitumor Immunity and Immunotherapy of Solid Tumors?
- (2016) E. Pure et al. Cancer Immunology Research
- Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells
- (2015) A. Lo et al. CANCER RESEARCH
- Triggering ubiquitination of IFNAR1 protects tissues from inflammatory injury
- (2014) S. Bhattacharya et al. EMBO Molecular Medicine
- Interferon Receptor Signaling in Malignancy: A Network of Cellular Pathways Defining Biological Outcomes
- (2014) E. N. Fish et al. MOLECULAR CANCER RESEARCH
- Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes
- (2014) J P Webber et al. ONCOGENE
- TGF-beta in CAF-mediated tumor growth and metastasis
- (2014) A. Calon et al. SEMINARS IN CANCER BIOLOGY
- Hope and Fear for Interferon: The Receptor-Centric Outlook on the Future of Interferon Therapy
- (2013) Serge Y. Fuchs JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
- (2013) C. Feig et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis
- (2013) Maria L. Wikberg et al. TUMOR BIOLOGY
- Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity
- (2013) L.-C. S. Wang et al. Cancer Immunology Research
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation
- (2012) Jacob Piehler et al. IMMUNOLOGICAL REVIEWS
- Vascular endothelial growth factor-induced elimination of the type 1 interferon receptor is required for efficient angiogenesis
- (2011) H. Zheng et al. BLOOD
- Biomechanical Remodeling of the Microenvironment by Stromal Caveolin-1 Favors Tumor Invasion and Metastasis
- (2011) Jacky G. Goetz et al. CELL
- Inflammatory signaling compromises cell responses to interferon alpha
- (2011) W-C HuangFu et al. ONCOGENE
- Cancer Exosomes Trigger Fibroblast to Myofibroblast Differentiation
- (2010) J. Webber et al. CANCER RESEARCH
- TGF-β-induced fibroblast activation protein expression, fibroblast activation protein expression increases the proliferation, adhesion, and migration of HO-8910PM
- (2009) He Chen et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice
- (2009) Angélica M. Santos et al. JOURNAL OF CLINICAL INVESTIGATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now